ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2298

Upper-Half Serum IgA (20+ TU/ml) and IgM (10+ IU/ml) Levels Significantly Predicted The Long-Term (mean 12 yrs) Onset Of Rheumatoid Arthritis When Combined, But Neither test Individually In Their Respective Full Ranges Of Values

Alfonse T. Masi1, Azeem A. Rehman1, Jean C. Aldag1, Huaping Wang2, Ned J. Goertzen3 and Marius C. Teodorescu4, 1Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, 2Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, IL, 3University of Illinois College of Medicine at Peoria, Peoria, IL, 4Microbiology, TheraTest Laboratories Inc, Lombard, IL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: epidemiologic methods and rheumatoid arthritis (RA), Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis-Clinical Aspects III: Outcome Measures, Socioeconomy, Screening, Biomarkers in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Serum rheumatoid factor (RF) is a major predictor of the new onset of rheumatoid arthritis (RA).  In very early arthritis patients, higher titers of both IgA and IgM RF isotypes predicted bone erosions at 2 years (A&R 2010; 62:1739-47).  However, no data have been reported on efficacy of IgA or IgM RF isotypes to predict new onset of RA.  This cohort study analyzed baseline IgA and IgM RF isotype levels as predictors of new onset of RA, and searched for factors associated with baseline levels of these biomarkers.

            Methods:   In 1974, baseline sera were obtained from a community-based cohort (n=21,061 adults) enrolled in the CLUE 1 follow up study.  In 1994, baseline pre-RA cases were identified, who subsequently developed ACR-positive RA, 3 to 20 (median 12) years after entry.  Four non-RA control (CN) cohort subjects were matched to each case on age, sex, and Caucasian race.  The RF isotype assays were performed by ELISA concurrently and without identification, on stored (-70ºC) baseline sera of 32 pre-RA and 119 CN subjects.  Median (Md) levels were determined for IgA (20 TU/ml) and IgM (10 IU/ml) RF isotypes from total subject sample values, which were then stratified into 4 gradient subgroups (1 = both < Md, 4 = both ≥ Md).  The subgroup with both RF isotypes lower than Md values (1) was used as baseline in odds ratio (OR, 95% CIs) prediction of RA for the other 3 subgroups (Table):

Results: Expected random frequencies were found for the CN in each of the 4 gradient categories, 31 (26%) of 119 in the highest subgroup, whereas pre-RA predominated in that subgroup, 17 (53%) of 32 (p = 0.005).  In univariate analyses (Table), category 4 predicted RA onset in total subjects, OR 2.74 (1.004 – 7.485). In males, category 4 also predicted RA onset, 5.05 (1.642 – 15.520), but not in females, 1.91 (0.593 – 6.193).  In a logistic regression (LR) model, the higher combined IgA/IgM RF category 4 was included as a dichotomous, independent factor (0 = no, 1 = yes), and predicted (p = 0.006) the dependent RA outcome, OR 3.16 (1.381 – 7.225).  The model included other baseline variables: cohort entry age; sex; a 7-category cigarette smoking history score, and years from entry to RA onset.  The smoking variable also independently predicted RA outcome, OR 1.28 (1.008 – 1.626).  Unlike category 4, neither RF isotype alone in full-range values predicted RA in LR models.  In other LR models, using the higher IgA/IgM RF category 4 as the dependent outcome variable, neither the cigarette gradient scores, nor individually-entered serum levels of acute phase proteins (CRP, ASAA, IL-1ra), inflammatory cytokines (IL-1B, IL-6, TNF-α), or selected receptors (sTNF-R1 and sIL-2Rα) were independent predictors.

Conclusion:   The combination of upper-half IgA and IgM RF levels was a significant predictor of long-term development of RA in total subjects and males.  Factors which influence the combined higher IgA/IgM RF isotype levels, as was found in pre-RA, deserve further study.


Disclosure:

A. T. Masi,
None;

A. A. Rehman,
None;

J. C. Aldag,
None;

H. Wang,
None;

N. J. Goertzen,
None;

M. C. Teodorescu,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/upper-half-serum-iga-20-tuml-and-igm-10-iuml-levels-significantly-predicted-the-long-term-mean-12-yrs-onset-of-rheumatoid-arthritis-when-combined-but-neither-test-individually-in-their/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology